Advertisement Teva Canada upgrades Ontario plants - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Teva Canada upgrades Ontario plants

Teva Canada is upgrading its Stouffville, Markham and Scarborough plants with the help of Ontario province in Canada.

The expansion of Stouffville plant and equipment deployment will allow Teva Canada to produce one billion more tablets of prescription based generic medicines per year.

Further, the expansion not only increases the supply of generic prescription drugs for Ontarians but also enables the pharma company to compete globally with new specialized generic prescription medications.

Teva Canada president and CEO Barry Fishman their expanded plant and new equipment will enable them to increase their capacity to service the needs of patients in Ontario and across Canada.